Molina Healthcare, Inc. (NYSE:MOH) has received a consensus rating of “Hold” from the thirteen ratings firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $155.89.
MOH has been the subject of several research reports. ValuEngine upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, November 29th. Morgan Stanley reduced their price objective on Molina Healthcare from $184.00 to $172.00 and set an “overweight” rating on the stock in a research note on Friday, August 23rd. Jefferies Financial Group cut Molina Healthcare from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $133.00 to $120.00 in a research note on Wednesday, October 30th. Finally, Deutsche Bank began coverage on shares of Molina Healthcare in a report on Thursday, September 12th. They issued a “buy” rating and a $145.00 price objective for the company.
In other Molina Healthcare news, Director Ronna Romney sold 375 shares of the stock in a transaction on Friday, November 8th. The stock was sold at an average price of $121.97, for a total value of $45,738.75. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Dale B. Wolf sold 3,500 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $135.51, for a total value of $474,285.00. Following the completion of the sale, the director now owns 8,461 shares in the company, valued at $1,146,550.11. The disclosure for this sale can be found here. Insiders own 0.77% of the company’s stock.
Shares of Molina Healthcare stock traded up $0.81 during trading on Tuesday, reaching $133.30. The company had a trading volume of 408,700 shares, compared to its average volume of 471,579. The company has a market cap of $8.31 billion, a price-to-earnings ratio of 12.03, a price-to-earnings-growth ratio of 1.22 and a beta of 1.16. The firm’s fifty day moving average is $127.53 and its 200-day moving average is $130.84. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.78 and a current ratio of 1.78. Molina Healthcare has a fifty-two week low of $105.28 and a fifty-two week high of $159.00.
Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.80 EPS for the quarter, topping the Zacks’ consensus estimate of $2.70 by $0.10. Molina Healthcare had a return on equity of 49.14% and a net margin of 4.47%. The business had revenue of $4.24 billion during the quarter, compared to the consensus estimate of $4.15 billion. During the same period last year, the firm earned $2.97 earnings per share. The company’s revenue for the quarter was down 9.7% compared to the same quarter last year. On average, research analysts anticipate that Molina Healthcare will post 11.55 EPS for the current fiscal year.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Read More: What is the S&P/ASX 200 Index?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.